ArticleScientific reports2026
Explainable AI for diabetic retinopathy detection using vision transformers.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The heterogeneous acquisition, variability of orientation, and subtle lesions continue to challenge the screening of diabetic retinopathy through color fundus photographs. We formulate DR grading as a binary triage task (No-DR vs DR) and propose the All-ViT Hybrid framework, integrating complementary pretrained transformer backbones within a stability-oriented training schedule (head-only warm-up, partial unfreezing), optimized using AdamW with OneCycle scheduling, class-weighted cross-entropy, and mixed precision. Preprocessing includes luminance-space CLAHE and retinal field-of-view masking, and data splitting is performed using stratified sampling to preserve class balance. We perform post-hoc threshold tuning and test-time augmentation (optional), which is available for operating-point control and robustness. Over the competitive baselines (ConvNeXt, MobileNetV3-Large, EfficientNet-B0, DenseNet201), All-ViT Hybrid has an Accuracy of 0.9754, F1 of 0.9761, Precision of 0.9658, Recall of 0.9866, and measures of agreement κ of 0.9509, MCC of 0.9511, and Jaccard of 0.9532. Compared to the best baseline, F1 achieves a gain of +1.11 percentage points, an improvement in accuracy of +1.13, and a recall improvement of +0.81 percentage points without compromising controllable precision and these experiments were conducted on the APTOS 2019 Blindness Detection dataset. These visualizations provide qualitative interpretability and are not quantitatively validated against lesion-level annotations due to dataset limitations. These findings suggest that integrating complementary transformer representations within a unified fusion pipeline provides strong and threshold-adjustable performance for DR triage under real-world variability. The framework remains modular and extensible, with potential applicability to larger input resolutions, multi-class grading, and multi-modal clinical settings. The future research program will test external generalization and probability calibration across devices and centers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.